Information For Authors
- Manuscript Submission Guidelines
- Author Benefits Program
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Medical Acupuncture is a journal with an international scope, focusing on the evolving specialty of medical acupuncture. The editor welcomes articles on all aspects of medical acupuncture, including research, education, clinical practice, technology, policy, ethics, law, schools of thought, history, and related disciplines.
All new manuscripts must be submitted online at: http://mc.manuscriptcentral.com/acupuncture. Please read ALL “the Instructions for Authors” before submitting; all papers must also adhere to the new STRICTA 2010 requirements (available online: http://www.stricta.info/
Please upload individual files of all manuscript materials—do NOT upload a single PDF file containing all text, figure, and table files of your article. Once all individual files are uploaded onto Manuscript Central, the system will automatically create a single PDF proof for you, and the peer-review process.
All material submitted should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as formulated by the International Committee of Medical Journal Editors. These requirements appear in their entirety (updated October 2007) online at www.icmje.org/index.html Note the requirement for the registration of clinical trials.
Please adhere to the new STRICTA 2010 (Standards for Reporting Interventions in Controlled Trials of Acupuncture), requirements available online at www.stricta.info/
All persons designated as authors must qualify for authorship. Criteria include substantial contributions to the following: (a) conception, design, and/or analysis and interpretation of data; (b) writing or revising the manuscript for intellectual content; and (c) final approval of the paper for publication. All 3 criteria must be met. Contributors who do not meet these 3 criteria should be listed, with their permission, in an acknowledgement paragraph.
The order of the author byline should be reached by consensus of the co-authors. All authors should be listed by full name, one major degree, and affiliations along with other pertinent information.
Biographical and contact information (including address, phone and fax numbers, email address) for all authors must be provided.
Once material is published in the Journal, it becomes the copyrighted property of Mary Ann Liebert, Inc. Permission must be obtained from Mary Ann Liebert, Inc. to publish in other medical journals.
The corresponding author is responsible for communicating with coauthors to make sure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright.
It is incumbent upon the submitting author to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the paper. Once a paper is accepted for publication, changes in authorship – including the page proof stage – are NOT permitted. Changes in authorship after publication are strictly prohibited.
All affiliations with, or financial involvement in, any entity with a financial interest in, or in competition with the article’s subject matter must be disclosed. This includes stock ownership, employment, consultancies, honoraria, grants, patents, and royalties.
Redundant or Duplicate Publication. Medical Acupuncture does not publish articles that have been submitted or published elsewhere.
Informed Consent, Study Ethics Approval, and Subject Confidentiality
When articles include reports of studies on human subjects, state in the Methods section that an appropriate review board or ethics committee approved the study. Authors who do not have formal ethics review committees should follow the principles of the Declaration of Helsinki (2013). In the Methods section, state that informed consent was obtained from subjects (specify oral or written).
In addition, text, photographs, and pedigrees should not reveal identifying information unless it is essential for scientific purposes (in which case, consent should be obtained). Masking the subjects’ eyes in photographs is often insufficient to protect their identity.
Animals. The principal author must state that if animals were used experimentally, permission was obtained from the appropriate committee(s), and that the animals were treated humanely and conformed to the standards of current ethical animal research practices.
Note: when uploading your figures and tables, please label them with the journal acronym, ACU, and the year, plus your last name and the figure number. Example: ACU.2008.Smith.Fig1.
PLEASE ENSURE THAT YOUR MAIN MANUSCRIPT TEXT FILE CONTAINS THE FOLLOWING:
- A title page which includes the title of the article, as well as ALL authors’ names, affiliations, email addresses, and contact information.
- An abstract (uploading your abstract into the appropriate field in Manuscript Central will NOT automatically incorporate it into the text file, so please include the abstract within the manuscript file).
- References section correctly formatted (see examples).
- Tables and figures should be uploaded as individual files.
- Do NOT upload a PDF of your text file.
Note that the new STRICTA 2010 requirements require that you identify the type of trial: that is Acupuncture for hiccups in the elderly adult: a randomized trial; Acupuncture used to stop smoking: an observational trial. The title page should include the full article title, names and affiliations of all authors, and corresponding biographical information for all authors, including mailing address, fax and telephone numbers, and email addresses. (Example John K. Jones, MD [Main credential only])
For original research, reviews, and meta-analyses, provide a structured abstract of no more than 250 words. Include information as applicable for the following headings: Background, Objective, Design, Setting, Patients (or Subjects), Intervention, Main Outcome Measures, Results, Conclusions, Randomizations (If applicable, elaborate), Blinding (Investigators and Subjects), Conclusions, Registration and Funding. For all other major manuscripts, include an unstructured abstract of no more than 250 words that summarizes the objective, main points, and conclusions of the article.
Underneath the abstract, provide 3–10 key words (preferably Medical Subject Heading (MeSH) terms) that will assist indexers and researchers using electronic databases such as MEDLINE.®
Introduction. Note Table 2/2ab new STRICTA 2010 (http:// www.stricta.info/) Provide a brief background for the article, including the rationale and hypothese for the study or observation. Do not present data from the current work.
Methods. The following should be taken into account:
1. Provide rationale for treatment, and style of acupuncture used.
2. Supply needling details: unilateral/bilateral points employed.
3. Number of needles inserted; needle type (gauge, length, manufacturer [include city, state, and country]); insertion depth; responses elicited (Qi); and whether twirled counterclockwise or clockwise.
4. Electrostimulator device (type, model, manufacturer [include city, state, and country]); time; stimulation frequency; which leads are designated negative and positive and where placed.
5. State treatment regimen: number of treatments, frequency (treatments per week, etc.); interventions employed such as moxibustion, cupping, herbs, etc.; treatment duration; environment: music, lighting, aromatics, etc.
Describe the selection of subjects, including demographics and study design. Describe the location and dates of the study. Identify the procedures in sufficient detail so others may replicate the results. Provide references to established methods and new techniques; provide the rationale for their use and also describe their limitations. Authors submitting review articles should describe the methods used to locate, select, extract, and synthesize data.
The principal author must state that verbal or written consent was obtained from the patient(s) when appropriate. The principal author must state whether a human research committee granted approval for treating and obtaining data or employing protocols that involved human subjects.
Statistics. As necessary, describe statistical methods and provide appropriate indicators of error or uncertainty (e.g., 95% confidence intervals). Specify any statistical software used.
Your article must follow as appropriate the sequence below which is the new STRICTA 2010 requirements.
The italicized 1–6 below is information that must appear in the METHODOLOGY. This is found in Table 1 of the new STRICTA 2010.
1. Acupuncture rationale 1abc as appropriate
2. Details of needling 2(a) to 2(g)
3. Treatment regimen 3ab
4. Other components of treatment 4ab
5. Practitioner Background 5
6. Control or Comparator interventions 6ab
Use the new STRICTA 2010 Table 2 to complete the METHODOLOGY section:
A. TRIAL DESIGN 3ab
B. PARTICIPANTS 4ab
C. INTERVENTIONS 5
D. OUTCOMES 6ab
E. SAMPLE SIZE 7ab
Use the new STRICTA 2010 Table 2 to complete the RANDOMIZATION section:
A. Sequence generation 8ab
B. Allocation Concealment 9
C. Implementation 10
D. Blinding 11ab
E. Statistical methods 12ab
Results. Present results in a logical sequence. Do not duplicate data in the text and tables/figures.
Use the new STRICTA 2010 Table 2 to complete the RESULTS section.
A. Participant flow 13ab
Baseline data 15
Numbers analyzed 16
Outcomes and Estimations 17ab
Ancillary Analyses 18
Discussion. The discussion section should summarize the results and their implications. This section should also discuss the rationale of acupoints used such as mechanisms of action; clinical implications and usefulness; and benefit to the patient.
Conclusion(s). Summarize the paper’s findings and their importance. This text may also give rise to questions, discuss ambiguous data, and recommend areas of further research.
Use the new STRICTA 2010 Table 2 to complete the DISCUSSION and OTHER INFORMATION sections. Note that we require a CONCLUSIONS section.
A. Limitations 20
B. Generalizability 21
C. Interpretation 22
A. Registration 23
B. Protocol 24
C. Funding 25
Many of the articles in our journal are singular case reports. In achieving publications of these articles it is obvious that some components of STRICTA may not be applicable. Nevertheless we need to strive and maintain the quality of this journal. We urge you to plan your articles carefully and remember a single case is interesting, but not conclusive and subjected to much scrutiny especially by the Editor-in-Chief and the reviewers.
Nomenclature and Abbreviations
Authors must conform to the standard nomenclature for medical acupuncture, listed at the end of these instructions. As a general rule, use only these abbreviations and those easily recognizable in the literature. The full term should appear at first mention, followed by the abbreviation in parentheses. Standard units of measure are acceptable to abbreviate without expansion. When discussing particular products, it is preferable to use the nonproprietary (generic) name or descriptive term throughout. If desired, the brand name can be included parenthetically at first mention.
At the end of the article, include a paragraph, when appropriate, acknowledging support for the work. It can include contributions that do not justify authorship, technical support, and financial and technical help. This is also an appropriate place to mention previous presentations (e.g., as an abstract or poster at a meeting).
Author Disclosure Statement
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” This text must be part of your actual manuscript file. In this portion of the article, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. This information will remain confidential while the article is being reviewed and will not influence the editorial decision. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at www.icmje.org/index.htlm#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist.”
Cite references within the text using superscript Arabic numbers (e.g., “as previously described.”1,4) List references in text in numerical order. Do not use “ibid,” but instead repeat the number of the citation. The reference list at the end of the article should be double-spaced and organized by Arabic numbers. Use journal abbreviations as provided by MEDLINE.® List all authors up to 6 authors. If there are more than 6 authors, list 3 and then et al. If references to personal communications or unpublished data are used, they are not to be included in the list of references. They should be referred to in the text in parentheses, including date. Include, among the references, articles accepted but not yet published; provide the journal, title, and the designation “In press.” If it is necessary to cite an abstract, this should be so designated. Authors are responsible for the accuracy of the references, and are reminded that inaccurate and dishonest references are highly frustrating to the reader, the cited author, and indexing services. Please follow the samples below. Translate titles of articles into English and place the original language in brackets.
Sample References: Journal article: Jobst KA. Acupuncture in asthma and pulmonary disease: an analysis of efficacy and safety. J Altern Complement Med. 1996;2(6):179–206.
Book: Ersser SJ. Nursing as a Therapeutic Activity: An Ethnography. Avebury, UK: Aldershot; 1997:371.
Edited book: Fulford KWM, Ersser SJ, Hope T, eds. Essential Practice in Patient-Centered Care. Oxford, UK: Blackwell Science; 1996.
Chapter in a book: Van Wijk R, Wiegant FA. Physiological effects of homeopathic medicines in closed vials: a critical evaluation. In: Endler PC, Schulte J, eds. Ultra High Dilution Physiology and Physics. Boston, MA: Kluwer Academic Publishers; 1994:81–98.
Abstract: van der Hamm IJ, Raemaekers M, van Wezel RJ, et al. Categorical and coordinate spatial relations in working memory: an fMRI study [abstract]. Brain Res. July 2009. doi:10.1016/j.brainres.2009.07.088.
Website: Include name of website, and URL, starting with www. Include month, day, and year accessed.
A minimum of 3 references is required. References should be numbered consecutively in the text; do not alphabetize the reference list, but present citations in numerical order to correspond with mention in the text. References cited only in tables or figures should be numbered in accordance with the order established by the first mention of that table or figure in the text.
Avoid citing “personal communications” unless they provide essential information; do not list them in the references but place them parenthetically in the text. Authors should obtain permission from the source of such communications and indicate the date they occurred and whether the communication was oral or written. Also include the first name, surname, and degree of the source.
Do NOT include tables or figures within your text file. All tables should be prepared in one collective file, preferably with one table to a page. Upload single file containing all tables to Manuscript Central as "Table(s)" under file designation. Number tables consecutively in the text as they appear. Provide a title for each table, as well as column headings. Be sure to cite all table(s) in text. Provide footnotes for explanatory material, using the following symbols in sequence: * † ‡ § || #. Identify statistical measures, such as mean (SD). Data from other sources require permission and a statement of such in a table footnote. The use of too many tables in relation to length of text may cause problems for journal page layout. Avoid duplicating data in text and tables/figures, with the exception of main outcomes.
Do NOT embed figures in the text file. Letters, numbers, and symbols should be clear and of sufficient size when printed in the Journal. If pictures of patients are used, either the subjects must be completely unidentifiable or written informed consent must be obtained and submitted.
Electronic submission of figures is permitted with the following caveats:
• Do NOT include any illustrations as part of your text file.
• Do NOT prepare any figures in Word as they are not usable.
• Line illustrations must be submitted at 600 dots per inch (dpi).
• Halftones and color photos should be submitted at a minimum of 300 dpi.
• Do not submit PowerPoint files.
• Save art as either .TIFF or .EPS files. Avoid submitting .jpg files.
• Color art must be saved as CYMK, not as RGB.
- Name figure files using only alphanumeric characters. Do not use symbols, dots, or dashes.
- File names should be formatted with first author’s last name and the figure number. (Ex: SmithFig1)
Figures reprinted from other sources should be acknowledged in the legend, and permission must be granted. The legend should be submitted as part of the text and not typed on the actual figure. Clearly identify all symbols and abbreviations, and explain scales if necessary. Any other explanatory information should be given in the legend.
Submission and Editing Process
All submissions must be in English. Appropriate use of the English language is a requirement for review and publication in Medical Acupuncture. For authors whose native language is not English, we suggest using a service that can aid in the translation and rewriting of material into correct and proper English usage. The Publisher offers this service with a subsidy from the author prior to official submission (contact: AuthorServices@liebertpub.com). It is important to note that employing the use of the Publisher’s service does not guarantee acceptance of any paper. All submissions are subject to peer review. The Journal prefers that the article be composed using a 12-point font in Microsoft Word. All accepted submissions are subject to copyediting.
Submit all manuscript components ONLINE via Manuscript Central at:http://mc.manuscriptcentral.com/acupuncture The author’s request to withdraw the manuscript after undergoing the editing process will result in possible penalty fees based on editing costs, and possible exclusion from future publishing in Medical Acupuncture.
Manuscript Review Process
Each manuscript will be initially reviewed by the Editor-in-Chief for preliminary acceptance or rejection. The manuscript is then forwarded to appropriate experts for review and scored appropriately (peer review). The manuscripts are categorized as fully accepted, accepted pending revisions, or rejected with recommendations for re-submission. After submission, no revisions or new versions will be accepted unless requested by the Editor-in-Chief.
Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.
STANDARD NOMENCLATURE FOR MEDICAL ACUPUNCTURE
READERS: The standard nomenclature was revised May 2002.
The following names and abbreviations are to be used in Medical Acupuncture. Recent changes in nomenclature have been adopted by the American Academy of Medical Acupuncture (AAMA) and are to be used in all articles submitted to the Journal. Please pay strict attention to these changes. For the most part, this is the system endorsed by the World Health Organization (WHO). Common English anatomical, physiological, and pathological terms are capitalized to indicate their Chinese medical meanings, for example, Lung, Blood, Heat Deficiency, etc. The Alphabetic Code was agreed on by participants and observers at a meeting of the WHO Scientific Group held in 1989.
STANDARD INTERNATIONAL NOMENCLATURE FOR MERIDIANS
Name of Meridian Alphabetic Code
Lung Meridian LU
Large Intestine Meridian LI
Stomach Meridian ST
Spleen Meridian SP
Heart Meridian HT
Small Intestine Meridian SI
Bladder Meridian BL
Kidney Meridian KI
Pericardium Meridian PC
Triple Energizer Meridian TE
Gallbladder Meridian GB
Liver Meridian LR
Governor Vessel (Dumai) GV
Conception Vessel (Renmai) CV
GV Dumai Governor Vessel
CV Renmai Conception Vessel
TV Chongmai Thoroughfare Vessel
BV Daimai Belt Vessel
YinHV Yinqiaomi Yin Heel Vessel
YangHV Yangqiaomai Yang Heel Vessel
YinLV Yinweima Yin Link Vesseli
YangLV Yangweimai Yang Link Vessel
Fu Hollow organs
Zang Solid organs
Front Mu Collecting points
Back Shu Transporting points
Sheng Generating cycle
Ke Controlling cycle
Ah Shi “Ouch” point
De Qi Arrival of Qi
Command and Special Points
Energy Levels or Axes
Tai Yang Tai Yin
Shao Yang Shao Yin
Yang Ming Jue Yin
RESPONDING TO ALLEGATIONS OF POSSIBLE MISCONDUCT
The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation. As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.
When allegations concern authors, the peer review and publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper. In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.
Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.
If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record. If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.
All allegations will be kept confidential.
DEFINITIONS OF SCIENTIFIC MISCONDUCT
Mary Ann Liebert, Inc., publishers generally follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).
Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:
- Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.
- Authorship Disputes: Deliberate misrepresentation of a scientist's contribution to the published work, or purposefully omitting the contributions of a scientist.
- Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.
- Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.
- Material failure to comply with legislative and regulatory requirements affecting research: Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.
- Conflict of Interest: Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.
- Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.
- Plagiarism: Purposely claiming another's work or idea as your own constitutes misconduct and/or fraud.
- Simultaneous Submission: Submitting a paper to more than one publication at the same time constitutes misconduct.
Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) option
Does your research funder have an open access mandate or would you like to expand the dissemination of your research?
The Liebert Open Access option enables authors to publish open access in our esteemed subscription-based journals.
The benefits of Liebert Open Access include:
- High visibility; open access articles are freely available online upon publication
- You retain copyright with the open access license allowing broad dissemination of your research
- You can freely share your article in repositories and research networks without restrictions
- Easy compliance with open access mandates
- Rigorous editorial and peer-review
- Targeted email announcement featuring a direct link to article
Identification and Marketing
Open access articles are listed with an OA icon in journal tables of content (TOC), TOC alerts, and in marketing announcements. Open access articles are highlighted and promoted in targeted email announcements to thousands of research leaders in your field.
Copyright and Licensing
If you choose to publish with open access, you will retain copyright of your article and a Creative Commons license will be applied. The liberal Creative Commons Attribution 4.0 (CC-BY) license is the default open access license used at Mary Ann Liebert, Inc., publishers. The CC-BY license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Ordering Open Access
Once your article has been accepted for publication in a journal, you will receive an email with information on ordering Liebert Open Access. If you would like more information about Liebert Open Access or would like to order open access, please email email@example.com.
Publishing open access includes an article publication charge (APC) and authors are asked to fill out a short open access order form. You can pay by credit card or receive an invoice to be returned with payment or via bank transfer. Please remember that traditional subscription journals can carry mandatory or optional author fees. The Liebert Open Access APC does not cover or replace existing publication or author fees.
Publishing biomedical or biotechnology research?
Biomedical researchers should consider publishing in BioResearch Open Access, a fully open access peer-reviewed journal dedicated to publishing top research in the biomedical and biotechnology fields. For details, please visit the information for authors on the journal website.
*Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.
Browse journals in the Liebert Open Access portfolio:
NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email firstname.lastname@example.org or visit Liebert Open Access for more information.